Publications by authors named "Rachel Sagar"

Claim this Profile
P
Pleiotropic effects of a recessive Col1a2 mutation occurring in a mouse model of severe osteogenesis imperfecta.
Michelangelo Corcelli, Rachel Sagar, Ellen Petzendorfer, Mohammad Mehedi Hasan, Fleur S van Dijk

PLoS One· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fetal therapies - (Stem cell transplantation; enzyme replacement therapy; in utero genetic therapies).
Rachel Sagar, Anna L David

Best Pract Res Clin Obstet Gynaecol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An exploratory open-label multicentre phase I/II trial evaluating the safety and efficacy of postnatal or prenatal and postnatal administration of allogeneic expanded fetal mesenchymal stem cells for the treatment of severe osteogenesis imperfecta in infants and fetuses: the BOOSTB4 trial protocol.
Rachel L Sagar, Eva Åström, Lyn S Chitty, Belinda Crowe, Anna L David

BMJ Open· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Maternal and fetal safety outcomes after in utero stem cell injection: A systematic review.
Rachel L Sagar, Lilian Walther-Jallow, Cecilia Götherström, Magnus Westgren, Anna L David

Prenat Diagn· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fetal and Maternal Safety Considerations for In Utero Therapy Clinical Trials: iFeTiS Consensus Statement.
Rachel Sagar, Graça Almeida-Porada, Karin Blakemore, Jerry K Y Chan, Mahesh Choolani

Mol Ther· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Publisher Correction: Human mid-trimester amniotic fluid (stem) cells lack expression of the pluripotency marker OCT4A.
Filipa Vlahova, Kate E Hawkins, Anna Maria Ranzoni, Kwan-Leong Hau, Rachel Sagar

Sci Rep· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fetal stem cell transplantation and gene therapy.
Rachel Sagar, Cecilia Götherström, Anna L David, Magnus Westgren

Best Pract Res Clin Obstet Gynaecol· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human mid-trimester amniotic fluid (stem) cells lack expression of the pluripotency marker OCT4A.
Filipa Vlahova, Kate E Hawkins, Anna Maria Ranzoni, Kwan-Leong Hau, Rachel Sagar

Sci Rep· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fetal Mesenchymal Stromal Cells: an Opportunity for Prenatal Cellular Therapy.
Rachel Sagar, Lilian Walther-Jallow, Anna L David, Cecilia Götherström, Magnus Westgren

Curr Stem Cell Rep· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of insurers in maternity safety.
Tim Draycott, Rachel Sagar, Susannah Hogg

Best Pract Res Clin Obstet Gynaecol· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis